Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Cerilliant
Merck
Queensland Health
Boehringer Ingelheim
Covington
McKesson
Fuji
Mallinckrodt

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018671

« Back to Dashboard

NDA 018671 describes SODIUM IODIDE I 123, which is a drug marketed by Cardinal Health 418, Ge Healthcare, and Mallinkrodt Nuclear, and is included in four NDAs. It is available from two suppliers. Additional details are available on the SODIUM IODIDE I 123 profile page.

The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.
Summary for 018671
Tradename:SODIUM IODIDE I 123
Applicant:Cardinal Health 418
Ingredient:sodium iodide i-123
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 018671
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM IODIDE I 123 sodium iodide i-123 CAPSULE;ORAL 018671 NDA Cardinal Health 418, Inc 48815-1001 N 48815-1001-1
SODIUM IODIDE I 123 sodium iodide i-123 CAPSULE;ORAL 018671 NDA Cardinal Health 418, Inc 48815-1001 N 48815-1001-5

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100uCi
Approval Date:May 27, 1982TE:AARLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200uCi
Approval Date:May 27, 1982TE:AARLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength400uCi
Approval Date:May 27, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chubb
Harvard Business School
Fish and Richardson
Federal Trade Commission
Julphar
Johnson and Johnson
Baxter
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot